X
skip to main content
Logo

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Terry Fox research team’s model for detecting lung cancer saves lives, is a world leader: study

    A pan-Canadian team of cancer researchers has developed a predictive model for detecting early-stage lung cancer in high-risk individuals with significantly greater accuracy than other leading models. This Terry Fox Research Institute study suggests the team’s innovative approach could be considered for use in lung cancer screening programs both in Canada and around the world.

    Read More View all notices

  • Save the date: The annual TFRI Ontario Node Symposium will be held Dec.4, 2017

    The annual Terry Fox Research Institute Ontario Node Symposium is just around the corner, and will be held on Dec. 4, 2017 at at the the MaRS Discovery Centre in Toronto.

    Read More View all notices

  • Canadian, international researchers find new candidate drivers, subtype diversity in study of whole-genome landscape for children’s brain cancer

    A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less harmful therapeutic options.

    Read More View all notices

  • Vancouver team identifies new class of molecules with potential in treating metastatic prostate cancer

    A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major characteristics of ERG-transformed prostate cancers.

    Read More View all notices

October is Liver Cancer Awareness Month 

Improving diagnostic techniques for the most difficult to detect cancers

Liver cancer is very challenging to diagnose, and confirmation of the disease often comes too late for treatment to be successful. Around 2,200 Canadians are diagnosed annually, and 1,100 people will die of liver cancer each year – more than two-thirds of them men.

Frustrated by these challenges, one TFRI-funded team is using innovate new imaging techniques to improve the outcomes of patients with hepatocellular carcinoma, the most common type of liver cancer. 

Read more  More research stories

Our researchers speak to the importance of mentoring the next generation of scientists:

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.


Back to Top